HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella first quarter results

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics and fragrance division sales advanced 6.4% to $117.2 mil. (€1=$.91) in first quarter despite weak markets in travel retail and Germany, Darmstadt, Germany company reports. Yardley of London contributed 5.1% to sales growth, yet lowered operating profit due to start-up costs, company noted. Wella acquired Yardley in December (1"The Rose Sheet" Dec. 17, 2001, p. 8). Consumer division sales grew 3.4% to $214.3 mil., slightly below expectations, Wella says. Professional division sales increased 17.3% to $353.7 mil. in Q1, accounting for over half of overall sales. Consolidated sales climbed 10.8% to $685.3 mil., while net profit was up nearly 18% to $21.8 mil. in first quarter...

You may also be interested in...



Wella Yardley North America Acquisition To Globalize Brand

Wella's acquisition of Yardley of London's North American business from New York City-based Wasserstein & Co. may give the company an opportunity to introduce its European stable of upscale Yardley offerings to the U.S. market, Yardley said

Investors Go Berserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel